Search - tctmd.com

Displaying 1 - 20 of 42

Sort: Relevancy | Date

Presentation TCT 2025

TCT 709: Oral Anticoagulation Versus Left Atrial Appendage Closure in Active Cancer Patients With Atrial Fibrillation: A Comparative Analysis of Safety and Efficacy

Presenter: Mehmet Cilingiroglu

October 27, 2025

Presentation TCT 2025

TCT 711: Outcomes of Left Atrial Appendage Closure vs. Oral Anticoagulation Following Catheter Ablation in Older and Younger Patients: A Sub-analysis of the OPTION Clinical Trial

Presenter: Devi G. Nair

October 27, 2025

Presentation TCT 2025

Treatment Adherence and Adverse Events After Combined TAVR and LAAC or TAVR and Oral Anticoagulation in Patients with Atrial Fibrillation: The WATCH-TAVR OAC Compliance Study

Presenter: Grant William Reed

October 25, 2025

Presentation TCT 2024

TCT 956: Validation of the VARC-HBR Criteria in TAVI Patients on Oral Anticoagulation

Presenter: Daniel Overduin

October 30, 2024

Presentation TCT 2024

TCT 186: Periprocedural Continuation Versus Interruption of Oral Anticoagulation During Transcatheter Aortic-Valve Implantation: Impact on Health-Related Quality of Life

Presenter: Dirk Jan van Ginkel

October 29, 2024

Presentation TCT 2024

TCT 183: Periprocedural Continuation Versus Interruption of Oral Anticoagulation During Transcatheter Aortic-Valve Implantation: Effect on Plasmatic Coagulation and Fibrinolysis

Presenter: Wilbert Bor

October 27, 2024

Presentation TCT 2023

Percutaneous Left Atrial Appendage Closure Versus Chronic Oral Anticoagulation for Non-Valvular Atrial Fibrillation: An Individual Patient Data Level Meta-Analysis of Randomized Controlled Trials

Presenter: Yousif Ahmad

October 25, 2023

Presentation TCT 2023

TCT 457: Impact of Uninterrupted Versus Interrupted Oral Anticoagulation on 30-Day Outcomes in Patients Undergoing Coronary Angiography

Presenter: Ting-Yu Wang

October 25, 2023

Presentation TCT 2022

TCT 359: Continued Oral Anticoagulation With Non-Vitamin K Antagonist Oral Anticoagulants Versus Vitamin K Antagonists in Transcatheter Aortic Valve Implantation

Presenter: Norman Mangner

September 19, 2022

Presentation TCT 2022

TCT 766: Exclusion of left atrial appendage with thrombus in a patient with contraindication of oral anticoagulation

Presenter: Claudio Cigalini

September 18, 2022

Presentation TCT 2021

Oral Anticoagulation Should Be the Default Strategy After LAAC

Presenter: Matthew J. Price

November 06, 2021

Presentation TCT 2021

PRAGUE-17: Three-Year Outcomes From a Randomized Trial of Left Atrial Appendage Closure Versus Direct Acting Oral Anticoagulation in Patients With Atrial Fibrillation

Presenter: Pavel Osmancik

November 05, 2021

Presentation TCT 2019

A Randomized Trial of Short-Course Dual Antiplatelet Therapy vs. Oral Anticoagulation to Prevent Cerebral Embolism After Transcatheter Aortic Valve Implantation

Presenter: Victor Alfonso Dias

September 28, 2019

Presentation TCT 2018

OAC-ALONE: A Randomized Trial of Oral Anticoagulation With vs Without Single Antiplatelet Therapy in Patients With Atrial Fibrillation Beyond One Year After Coronary Stent Implantation

Presenter: Gregg W. Stone, Yukiko Nakano

September 24, 2018

Presentation TCT 2018

Periprocedural Management of Anticoagulation in Patients With Nonvalvular Atrial Fibrillation

Presenter: Davide Capodanno, Giulio Stefanini, Robert A. Byrne

September 23, 2018

Presentation TCT 2018

US and ESC Guidelines and Consensus on Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing PCI

Presenter: Davide Capodanno, Giulio Stefanini, Dominick J. Angiolillo

September 23, 2018

Presentation TCT 2018

In 2018 When Is Warfarin Therapy Required vs Acceptable, and How Should it Be Dosed After PCI?

Presenter: Davide Capodanno, Giulio Stefanini, Freek W.A. Verheugt

September 23, 2018

Presentation TCT 2018

Has PIONEER and REDUAL Changed My Practice? What Are the Outstanding Issues?

Presenter: Davide Capodanno, Giulio Stefanini, C. Michael Gibson

September 23, 2018

Presentation TCT 2018

Pharmacotherapy Challenges and Possible Solutions in the PCI Patient on Chronic Oral Anticoagulation

Presenter: Davide Capodanno, Giulio Stefanini, Tullio Palmerini

September 23, 2018

Presentation TCT 2018

Chronic Oral Anticoagulation After Stenting: Strategy in Belarus

Presenter: Walter Desmet, Guy J. Friedrich, Oleg Polonetsky

September 22, 2018

Advertisement

TCT 709: Oral Anticoagulation Versus Left Atrial Appendage Closure in Active Cancer Patients With Atrial Fibrillation: A Comparative Analysis of Safety and Efficacy

TCT 711: Outcomes of Left Atrial Appendage Closure vs. Oral Anticoagulation Following Catheter Ablation in Older and Younger Patients: A Sub-analysis of the OPTION Clinical Trial

Treatment Adherence and Adverse Events After Combined TAVR and LAAC or TAVR and Oral Anticoagulation in Patients with Atrial Fibrillation: The WATCH-TAVR OAC Compliance Study

TCT 956: Validation of the VARC-HBR Criteria in TAVI Patients on Oral Anticoagulation

TCT 186: Periprocedural Continuation Versus Interruption of Oral Anticoagulation During Transcatheter Aortic-Valve Implantation: Impact on Health-Related Quality of Life

TCT 183: Periprocedural Continuation Versus Interruption of Oral Anticoagulation During Transcatheter Aortic-Valve Implantation: Effect on Plasmatic Coagulation and Fibrinolysis

Percutaneous Left Atrial Appendage Closure Versus Chronic Oral Anticoagulation for Non-Valvular Atrial Fibrillation: An Individual Patient Data Level Meta-Analysis of Randomized Controlled Trials

TCT 457: Impact of Uninterrupted Versus Interrupted Oral Anticoagulation on 30-Day Outcomes in Patients Undergoing Coronary Angiography

TCT 359: Continued Oral Anticoagulation With Non-Vitamin K Antagonist Oral Anticoagulants Versus Vitamin K Antagonists in Transcatheter Aortic Valve Implantation

TCT 766: Exclusion of left atrial appendage with thrombus in a patient with contraindication of oral anticoagulation

Oral Anticoagulation Should Be the Default Strategy After LAAC

PRAGUE-17: Three-Year Outcomes From a Randomized Trial of Left Atrial Appendage Closure Versus Direct Acting Oral Anticoagulation in Patients With Atrial Fibrillation

A Randomized Trial of Short-Course Dual Antiplatelet Therapy vs. Oral Anticoagulation to Prevent Cerebral Embolism After Transcatheter Aortic Valve Implantation

OAC-ALONE: A Randomized Trial of Oral Anticoagulation With vs Without Single Antiplatelet Therapy in Patients With Atrial Fibrillation Beyond One Year After Coronary Stent Implantation

Periprocedural Management of Anticoagulation in Patients With Nonvalvular Atrial Fibrillation

US and ESC Guidelines and Consensus on Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing PCI

In 2018 When Is Warfarin Therapy Required vs Acceptable, and How Should it Be Dosed After PCI?

Has PIONEER and REDUAL Changed My Practice? What Are the Outstanding Issues?

Pharmacotherapy Challenges and Possible Solutions in the PCI Patient on Chronic Oral Anticoagulation

Chronic Oral Anticoagulation After Stenting: Strategy in Belarus

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content